Clinical Trials
4 trialsNCT04975958 2025-06-22
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
Adlai Nortye Biopharma Co., Ltd.
Phase 1 Completed
NCT04432857 2024-06-27
AN0025 and Pembrolizumab Combination in Advanced Solid Tumors
Adlai Nortye Biopharma Co., Ltd.
Phase 1 Active not recruiting
NCT03152370 2021-10-04
PRAER 1
Adlai Nortye Biopharma Co., Ltd.
Phase 1 Completed
NCT02540291 2020-02-17
Study of E7046 in Subjects With Selected Advanced Malignancies
Eisai Inc.
Phase 1 Terminated